Skip to content

Freezor Max Cardiac Cryoablation Catheter

by Medtronic Cryocath, LP

PMA P100010

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None ongoing

1 closed

Documents

PMA P100010↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP100010 Date17 Dec 2010ApprovedStatusActive

Recalls

1 recall · FDA

    • Terminated Z-0149-2012 FDA Unclassified (pre-2012) initiated 29 Aug 2011

    Medtronic CryoCath has identified specific lots of Arctic Front CryoAblation Catheters that were distributed with incorrect programming that may result in false expired catheter notifications. Impacted lots are 21571, 25375, 25376, 25377, and 25381 of the Arctic Front Catheter Model Number 2AF282. Medtronic CryoCath is communicating this information to the FDA. On affected catheters, the incor

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Trade Name
Arctic Front Cryocatheter System
Generic Name
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
PMA Number
FDA Product Code
OAE
Device Class
Class III
Advisory Committee
Cardiovascular
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Freezor Max Cardiac Cryoablation Catheter is a percutaneous cardiac ablation device designed for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. It is part of the Arctic Front Cryocatheter System and is classified as a Class III device under FDA regulations.

This catheter is supplied sterile and intended for single-use in electrophysiology labs or cardiac catheterization suites. It is not MRI safe and must be stored according to manufacturer specifications. Authorization is granted via FDA PMA P100010.

Other devices from Medtronic Cryocath, LP

See all devices from Medtronic Cryocath, LP →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Freezor Max Cardiac Cryoablation Catheter used for?

    The device is indicated for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, as stated in the approval documentation for the Arctic Front Cryocatheter System.

  • Is the Freezor Max Cardiac Cryoablation Catheter reusable?

    No, the device is supplied sterile and intended for single-use only, as is standard for percutaneous cardiac ablation catheters to prevent cross-contamination and ensure patient safety.

  • What regulatory authorization does the Freezor Max Cardiac Cryoablation Catheter have?

    The device has received FDA Premarket Approval (PMA) under number P100010, which grants it legal authorization for marketing and use in the United States.